Applicability and results of liver transplant combined with neoadjuvant chemo-radiotherapy in the treatment of unresectable hilar cholangiocarcinoma

Alternate Title: Aplicabilidad y resultados del trasplante hepático combinado con quimiorradioterapia neoadyuvante en el tratamiento del colangiocarcinoma perihiliar irresecable (Spanish; Castilian)

Authors: Dopazo, Cristina ^⁎, Lladó, L., Fondevila, C., Macarulla, T., Navalpotro, B., Ramos, E., Fabregat, J., Laquente, B., Navasa, M., Castells, L., Bilbao, I., García Valdecasas, J.C., Charco, R.

Source: In Cirugía Española (English Edition) March 2021 99(3):190-199

Aplicabilidad y resultados del trasplante hepático combinado con quimiorradioterapia neoadyuvante en el tratamiento del colangiocarcinoma perihiliar irresecable

Alternate Title: Applicability and results of liver transplant combined with neoadjuvant chemo-radiotherapy in the treatment of unresectable hilar cholangiocarcinoma (English)

Authors: Dopazo, Cristina, Lladó, L., Fondevila, C., Macarulla, T., Navalpotro, B., Ramos, E., Fabregat, J., Laquente, B., Navasa, M., Castells, L., Bilbao, I., C García Valdecasas, J., Charco, R.

Source: In Cirugia Espanola March 2021 99(3):190-199

Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients

Authors: Bodro, M., Sanclemente, G., Crespo, G., Linares, L., Marcos, M.A., Marco, F., Miquel, R., Forns, X., Navasa, M., Moreno, A.

Source: In Transplantation Proceedings June 2018 50(5):1437-1443

Mannose-Binding Lectin–Deficient Donors Increase the Risk of Bacterial Infection and Bacterial Infection–Related Mortality After Liver Transplantation

Authors: Lombardo-Quezada, J., Sanclemente, G., Colmenero, J. ^*, Español-Rego, M., Arias, M.T., Ruiz, P., Mauro, E., Sastre, L., Crespo, G., Rimola, A., Moreno, A., Lozano, F., Navasa, M.

Source: In American Journal of Transplantation January 2018 18(1):197-206

Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study

Authors: Benito, N., García-Vázquez, E., Horcajada, J.P., González, J., Oppenheimer, F., Cofán, F., Ricart, M.J., Rimola, A., Navasa, M., Rovira, M., Roig, E., Pérez-Villa, F., Cervera, C., Moreno, A.

Source: In Clinical Microbiology and Infection July 2015 21(7):651-658

FuelCell2012-91112 SOFC Modeling at the Cell Scale Including Hydrogen and Carbon Monoxide as Electrochemically Active Fuels
Fuel cell science, engineering and technology

Authors: Andersson, M., Navasa, M., Yuan, J., Sunden, B.

Source: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON FUEL CELL SCIENCE ENGINEERING AND TECHNOLOGY. CONF 10th:281-292

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN083564037&indx=1&recIds=ETOCCN083564037

Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites
Current trends in theory and practice of computer science; SOFSEM 2012

Authors: Corradi, F., Brusasco, C., Fernandez, J., Vila, J., Ramirez, M. J., Seva-Pereira, T., Fernandez-Varo, G., Mosbah, I. B., Acevedo, J., Silva, A., Rocco, P. R. M., Pelosi, P., Gines, P., Navasa, M.

Source: LECTURE NOTES IN COMPUTER SCIENCE. (7147):239-244

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN081106615&indx=1&recIds=ETOCCN081106615

Tuberculosis in Solid Organ Transplant Recipients at a Tertiary Hospital in the Last 20 Years in Barcelona, Spain
Catalan Transplantation Society

Authors: Garcia-Goez, J.F., Linares, L., Benito, N., Cervera, C., Cofan, F., Ricart, M.J., Navasa, M., Perez-Villa, F., Gonzalez, J., Moreno, A.

Source: TRANSPLANTATION PROCEEDINGS. 41(6):2268-2272

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN073862303&indx=1&recIds=ETOCCN073862303

Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study

Authors: Millán, O., Rafael-Valdivia, L., San Segundo, D., Boix, F., Castro-Panete, M.J., López-Hoyos, M., Muro, M., Valero-Hervás, D., Rimola, A., Navasa, M., Muñoz, P., Miras, M., Andrés, A., Guirado, L., Pascual, J., Brunet, M.

Source: In Clinical Immunology October 2014 154(2):141-154

Spontaneous Bacterial Peritonitis/Infections in Cirrhosis
Baveno international consensus workshop:; Portal hypertension IV

Authors: Navasa, M., Rodes, J.

Source: PORTAL HYPERTENSION. (4):243-261

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN059532387&indx=1&recIds=ETOCCN059532387

Liver Stiffness 1 Year After Transplantation Predicts Clinical Outcomes in Patients With Recurrent Hepatitis C

Authors: Crespo, G. ^*, Lens, S., Gambato, M., Carrión, J.A., Mariño, Z., Londoño, M.-C., Miquel, R., Bosch, J., Navasa, M., Forns, X.

Source: In American Journal of Transplantation February 2014 14(2):375-383

Liver transplantation in Spain

Authors: de la Rosa, G., Fondevila, C., Navasa, M.

Source: LIVER TRANSPLANTATION -PHILADELPHIA-. 22(9):1259-1264

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN380188179&indx=1&recIds=ETOCRN380188179

Rapidity of fibrosis progression in liver transplant recipients with recurrent hepatitis C is influenced by toll-like receptor 3 polymorphism

Authors: Citores, M. J., Prez-Pulgar, S., Duca, A., Crespo, G., la Fuente, S., Vilches, C., Navasa, M., Cuervas-Mons, V.

Source: CLINICAL TRANSPLANTATION. 30(7):810-818

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN379568589&indx=1&recIds=ETOCRN379568589

Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection

Authors: Ferrer-Fbrega, J., Forner, A., Liccioni, A., Miquel, R., Molina, V., Navasa, M., Fondevila, C., Garca-Valdecasas, J. C., Bruix, J., Fuster, J.

Source: HEPATOLOGY -BALTIMORE THEN ORLANDO-. 63(3):839-849

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN375595355&indx=1&recIds=ETOCRN375595355

Survival benefit of liver transplantation in Catalonia: A 2007–13 analysis

Authors: Colmenero, J., Lombardo, J., Trota, N., Crespo, G., Bilbao, I., Rafecas, A., Xiol, X., Castells, L., Baliellas, C., Ruiz, P., Biggins, S., Fondevila, C., Tort, J., Navasa, M.

Source: Journal of hepatology. 68(S1):S375-S377

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100059932658.0x000001&indx=1&recIds=ETOCvdc_100059932658.0x000001

The Biliary Complications in Live Donor Liver Transplant Do Not Affect the Long-Term Results

Alternate Title: Las complicaciones biliares en el trasplante hepático de donante vivo no afectan los resultados a largo plazo (Spanish; Castilian)

Authors: Sánchez Cabús, S., Calatayud, D., García-Roca, R., Ferrer, J., Martí, J., Navasa, M., Rimola, A., Fondevila, C., Fuster, J., García-Valdecasas, J.C.

Source: In Cirugía Española (English Edition) January 2013 91(1):17-24

Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes

Authors: Rodriguez, E., Henrique Pereira, G., Sol, E., Elia, C., Barreto, R., Pose, E., Colmenero, J., Fernandez, J., Navasa, M., Arroyo, V.

Source: LIVER TRANSPLANTATION -PHILADELPHIA-. 21(11):1347-1354

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN381182147&indx=1&recIds=ETOCRN381182147

Advances in the Treatment of Spontaneous Bacterial Peritonitis
Therapy in liver diseases

Authors: Navasa, M.

Source: THERAPY IN LIVER DISEASES -INTERNATIONAL MEETING-. :407-410

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN047516626&indx=1&recIds=ETOCCN047516626

Efficacy of a multispecialty, multidisciplinary strategy to improve the level of awareness and control of cardiovascular risk factors after liver transplantation

Authors: Viñals, C., Sastre, L., Garcia, R., Amor, A.J., Yago, G., Hervas, A., Sanchez, L., Trabal, J., Molero, J., Escude, L., Pagano, G., Blasco, M., Gelabert, R., Ruiz, P., Colmenero, J., Navasa, M., Crespo, G., Ortega, E.

Source: In Atherosclerosis August 2022 355

Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial

Authors: Winston, D.J. ^*, Saliba, F., Blumberg, E., Abouljoud, M., Garcia-Diaz, J.B., Goss, J.A., Clough, L., Avery, R., Limaye, A.P., Ericzon, B.G., Navasa, M., Troisi, R.I., Chen, H., Villano, S.A., Uknis, M.E.

Source: In American Journal of Transplantation November 2012 12(11):3021-3030